The current P/E ratio for West Pharmaceutical Services stock as of May 7, 2024 is 48.02. This is calculated based on the TTM EPS of $7.67 and the stock price of $368.35 per share. The PE ratio has decreased by 4.3% from its last 4 quarters average of 50.2.
The average historical PE ratio of West Pharmaceutical Services for the last ten years is 44.09. The current price-to-earnings ratio of 48.02 is 9% more than the historical average. Analyzing the last ten years, WST's PE ratio reached its highest point in the Sep 2020 quarter at 64.99, when the price was $274.9 and the EPS was $4.23. The lowest point was recorded in the Jun 2014 quarter, when it reached 26.04 with a price of $42.18 and an EPS of $1.62.
Maximum annual increase: 52.25% in 2015
Maximum annual decrease: -43.33% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 44.13 | 47.59% |
| 2022 | 29.9 | -43.33% |
| 2021 | 52.76 | -12.85% |
| 2020 | 60.54 | 31.69% |
| 2019 | 45.97 | 31.31% |
| 2018 | 35.01 | -27.62% |
| 2017 | 48.37 | 11.76% |
| 2016 | 43.28 | -4.42% |
| 2015 | 45.28 | 52.25% |
| 2014 | 29.74 | -2.4% |
The current PE ratio of WST is above its 3, 5 and 10-year averages.
WST's PE ratio is less than its peer stock BDX, but it is above JNJ's and SYK's. West Pharmaceutical Services's current PE ratio of 48.02 is more than the average of its peers, which is 27.43.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BAX Baxter International Inc | 6.84 | $18.22B |
| JNJ Johnson & Johnson | 9.76 | $358.47B |
| MDT Medtronic plc | 25.89 | $108.28B |
| TFX Teleflex Inc | 31.97 | $9.44B |
| SYK Stryker Corp | 37.21 | $125.44B |
| WST West Pharmaceutical Services Inc | 47.8 | $26.71B |
| BDX Becton Dickinson & Co | 51.45 | $67.51B |
| ICUI Icu Medical Inc | N/A | $2.45B |
| PLL Piedmont Lithium Inc | N/A | $253.82M |
As of May 7, 2024, WST stock has a price to earnings ratio of 48.02.
Over the last 3 years, the average PE ratio for WST stock is 44.96.
Over the last 5 years, the average PE ratio for WST stock is 47.39.
Over the last ten years, the quarterly PE ratio reached its highest level at 64.99 in the Sep 2020 quarter.
The current PE ratio of WST is 9% higher than the 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (May 7, 2024), West Pharmaceutical Services's share price is $368.35. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $7.67. Therefore, West Pharmaceutical Services's price to earnings ratio for today is 48.02. PE RATIO(48.02) = STOCK PRICE($368.35) / TTM EPS($7.67)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.